QOL After APBI (Multicatheter Brachytherapy) Versus WBI: 5-Year Results, Phase 3 GEC-ESTRO Trial (2018) Schaefer R, Strnad V, Polgar C, Uter W, Hildebrandt G, Ott OJ, Kauer-Dorner D, et al. Conference contribution NAR score as surrogate for disease-free survival in the CAO/ARO/AIO-04 phase 3 rectal cancer trial (2018) Fokas E, Fietkau R, Hartmann A, Hohenberger W, Grützmann R, Ghadimi M, Liersch T, et al. Conference contribution Quality assurance for interstitial brachytherapy using an EMT system integrated into an afterloader (2018) Kallis K, Strnad V, Fietkau R, Bert C Conference contribution Measuring the systemic immune-modulating effects of radiation (2018) Frey B, Gaipl U Conference contribution Fractionated SBRT for adrenal metastasis: contributing to local tumor control with modest toxicity (2018) Knippen S, Burjakow K, Putz F, Knippen A, Achterberg N, Lettmaier S, Fietkau R Conference contribution Implementation of registration quality assurance (2018) Anderle K, Brandt T, Wölfelschneider J, Bert C, Graeff C Conference contribution Examination of the automatic fiducial marker detection on the Vero system (2018) Ziegler M, Brandt T, Lettmaier S, Fietkau R, Bert C Conference contribution ESTRO-ACROP guideline: Interstitial multi-catheter breast brachytherapy as Accelerated Partial Breast Irradiation alone or as boost - GEC-ESTRO Breast Cancer Working Group practical recommendations (2018) Strnad V, Major T, Polgar C, Lotter M, Guinot JL, Gutierrez-Miguelez C, Galalae R, et al. Journal article Union of light ion therapy centers in Europe (ULICE EC FP7) - Objectives and achievements of joint research activities (2018) Poetter R, Balosso J, Baumann M, Bert C, Davies J, Enghardt W, Fossati P, et al. Journal article Systemic effects of radiotherapy: immune mechanisms, pre-clinical data and clinical evidence (2018) Gaipl U Conference contribution